( May 15, 2026, 12:26 PM EDT) -- WASHINGTON, D.C. — U.S. Supreme Court on May 14 left in place nationwide access to mail-order mifepristone, one of two drugs used to induce early termination of pregnancy, granting a stay of a Fifth Circuit U.S. Court of Appeals decision that granted Louisiana’s motion to stay the U.S. Food and Drug Administration’s 2023 decision that removed the in-person dispensing requirement for the drug....